Management of Suboptimal Sentinel Lymph Node Biopsy

Introduction to Sentinel Lymph Node Biopsy

The American Society of Clinical Oncology recommends that a specimen containing only fat after sentinel lymph node biopsy represents a failed or inadequate procedure, requiring repeat sentinel lymph node mapping and biopsy or formal axillary lymph node dissection if repeat mapping is not feasible 1, 2
Pathologists must carefully dissect fatty nodules to identify all lymph nodes, and when only fat is present after dissection, it indicates no lymph node was successfully removed 1, 2
For the sentinel lymph node approach to be effective, surgeons must identify and remove all true sentinel lymph nodes, and pathologists must carefully examine them 1, 2

Ensure the pathologist has thoroughly examined the specimen with careful dissection of all fatty tissue to confirm no lymph node tissue is present 1, 2, 3
Each sentinel lymph node should be submitted in a separate cassette or identified by colored ink to permit accurate assessment 1, 2
Repeat sentinel lymph node mapping and biopsy should be performed if technically feasible 1, 2
If repeat mapping is not feasible or fails, proceed to formal level I and II axillary lymph node dissection to ensure adequate staging 1, 2, 4

For melanoma, meticulous pathologic examination of all sentinel nodes is mandatory, with serial sectioning and immunohistochemical staining 5, 6, 7, 8
For patients with stage IB or II melanoma, sentinel lymph node biopsy should be discussed and offered 5, 6, 7, 8
For breast cancer, accurate identification of node metastases is the firm basis on which appropriate treatment decisions are made 1, 2, 3

Intraoperative confirmation using a gamma probe should verify radioactive counts in the excised tissue before concluding the procedure 1, 2
Visual inspection for blue dye and palpation for firm nodular tissue within the fat can help identify lymph nodes intraoperatively 1, 2, 3
Lymphoscintigraphic imaging before surgery can demonstrate the expected location and number of sentinel nodes, guiding more complete removal 2

Do not assume a specimen is adequate based solely on visual appearance or size—pathologic confirmation of lymph node tissue is essential 1, 2, 3
Do not proceed with observation alone when no lymph node tissue was obtained, as this leaves the patient unstaged and potentially undertreated 1, 2
Do not delay addressing this issue—staging information is critical for determining adjuvant therapy, and delayed procedures may be more technically challenging 1, 2